I believe Les meant all of the case studies that were collected.
True they weren't two years ago. They were for Tollovid and patients with covid. Then when NOTHING PANNED OUT (with either Tollovid or Tollovir) GC turned to studying Long Covid to keep this turd breathing.
Good for GC. Never let a failure stop you. Just re-set the goal posts. Can't get any EUA's or headway for treating Covid. Turn to LONG Covid. lol What a freakin joke this ticker is.